Correspondence 0001178913-24-002984 from MediWound Ltd. (MDWD)
MediWound Ltd.
Date: Sept. 5, 2024 · CIK: 0001593984 · Accession: 0001178913-24-002984
AI Filing Summary & Sentiment
File numbers found in text: 333-281843
Letter
Via EDGAR Transmission Division of Corporation Finance Securities and Exchange Commission MediWound Ltd. Registration Statement on Form F-3 Filed August 29, 2024 Registration No. 333-281843
Dear Mr. Buchmiller:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective on September 9, 2024 at 4:00 p.m. Eastern Time or as soon thereafter as practicable, or at such later time as MediWound Ltd. (the “Company”) or its counsel may request via telephone call to the staff. Please contact Michael J. Rosenberg of Latham & Watkins LLP, counsel to the Company, at (212) 906-1829, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
Sincerely yours,
MediWound Ltd.
Show Raw Text
CORRESP
1
filename1.htm
MediWound Ltd.
42 Hayarkon Street
Yavne 8122745, Israel
+972 (77) 971-4100
September 5, 2024
Via EDGAR Transmission
Tim Buchmiller
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
MediWound Ltd.
Registration Statement on Form F-3
Filed August 29, 2024
Registration No. 333-281843
Dear Mr. Buchmiller:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as
amended, we hereby request the acceleration of the effective date of the above-referenced Registration Statement so that it will become effective on September 9, 2024 at 4:00 p.m. Eastern Time or as soon thereafter as practicable, or at such later
time as MediWound Ltd. (the “Company”) or its counsel may request via telephone call to the staff. Please contact Michael J. Rosenberg of Latham & Watkins
LLP, counsel to the Company, at (212) 906-1829, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
Sincerely yours,
MediWound Ltd.
By:
/s/ Hani Luxenburg
Name: Hani Luxenburg
Title: Chief Financial Officer
cc:
Yaron Meyer, MediWound Ltd.
Joshua Kiernan, Latham & Watkins LLP
Nathan Ajiashvili, Latham & Watkins LLP
Shachar Hadar, Meitar | Law Offices
Jonathan Nathan, Meitar | Law Offices